Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities
Date:1/3/2011

DETROIT, Jan. 3, 2011 /PRNewswire/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that based on remediation efforts to date, it does not expect to commence the manufacture and distribution of products from its Detroit facility by the end of Caraco's Fiscal Year 2011, ending March 31, 2011. The Company had previously disclosed its belief that two products would commence manufacture in the Detroit facility prior to the end of Fiscal 2011. As provided under the terms of the Consent Decree of Condemnation, Forfeiture and Permanent Injunction entered into with the FDA on September 29, 2009, before resuming the manufacture and distribution of any product from the Company's facilities, a number of significant steps and processes are required to be completed, and certifications and approvals from both outside experts (current good manufacturing practice "cGMP" consultants) and the FDA are to be obtained.  In evaluating and discussing with the cGMP experts the remediation steps completed to date and those yet to be completed, the Company has determined that it will not be able to begin the manufacture and distribution of products by the end of Fiscal Year 2011.  The Company's remediation efforts towards the resumption of manufacturing and distribution from its facilities are still ongoing, but the Company is unable to predict when such manufacturing and distribution will resume.  As previously disclosed, and as always is the case in matters such as these, there is no assurance that the remediation efforts will be successful or result in resolution of the FDA compliance issues.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forw
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma
2. Independent Committee of Caraco Board Retains Independent Advisors for Consideration of Sun Pharma Proposal to Purchase Outstanding Shares and Caraco Acknowledges Filing of Purported Class Action Lawsuits
3. Independent Committee of Caraco Board to Consider Sun Pharma Proposal to Purchase Outstanding Shares
4. Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares
5. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2011
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of Eddie Munson to Board of Directors
8. Caraco Pharmaceutical Laboratories, Ltd. Announces G.P. Singh Sachdeva Is Appointed as Chief Operating Officer
9. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Flomax®
10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets
11. Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... /PRNewswire-iReach/ -- "North America Orthopedic Braces and Supports Market ... North America Orthopedic Braces and Supports market. The report ... (in units) and average price data (in US dollars), ... Supports , Ankle Braces and Supports , ... and Supports. Photo - ...
(Date:7/24/2014)... -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) today ... 2014. Three Months Ended 06/30/14Three Months Ended 06/30/13 ,  Percentage ... 51% Non-GAAP Net Sales , $278.8 Million , $196.1 ... , $1.12 , 37% Non-GAAP Diluted ... 37%  Six Months Ended 06/30/14Six Months Ended 06/30/13 , ...
(Date:7/24/2014)... 24, 2014  To help health care organizations ... could impact patient care and the bottom line, ... , "Innovations in Cardiovascular Devices."  ... and details on promising new technologies that can ... how these options impact the supply chain.   According ...
Breaking Medicine Technology:North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5Questcor Reports Record Second Quarter Financial Results 2Questcor Reports Record Second Quarter Financial Results 3Questcor Reports Record Second Quarter Financial Results 4Questcor Reports Record Second Quarter Financial Results 5Questcor Reports Record Second Quarter Financial Results 6Questcor Reports Record Second Quarter Financial Results 7Questcor Reports Record Second Quarter Financial Results 8Questcor Reports Record Second Quarter Financial Results 9Questcor Reports Record Second Quarter Financial Results 10Questcor Reports Record Second Quarter Financial Results 11Questcor Reports Record Second Quarter Financial Results 12Questcor Reports Record Second Quarter Financial Results 13Questcor Reports Record Second Quarter Financial Results 14Questcor Reports Record Second Quarter Financial Results 15Questcor Reports Record Second Quarter Financial Results 16Questcor Reports Record Second Quarter Financial Results 17Questcor Reports Record Second Quarter Financial Results 18Questcor Reports Record Second Quarter Financial Results 19Questcor Reports Record Second Quarter Financial Results 20Questcor Reports Record Second Quarter Financial Results 21Questcor Reports Record Second Quarter Financial Results 22Questcor Reports Record Second Quarter Financial Results 23Questcor Reports Record Second Quarter Financial Results 24Questcor Reports Record Second Quarter Financial Results 25Questcor Reports Record Second Quarter Financial Results 26Questcor Reports Record Second Quarter Financial Results 27Questcor Reports Record Second Quarter Financial Results 28New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3
...  TSH testing, the gold standard in hypothyroid diagnosis, may ... new article titled Hormone Replacement Therapy in ... Questions for the Future. Estrogen, Progesterone, Testosterone, and Thyroid ... article, independently written and published, is a broad study ...
... Jan. 2, 2012 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... call on Tuesday, January 3, 2012 at 8:30 a.m. Eastern ... ongoing patent litigation with Genentech, Inc., a member of the ... Conference Call InformationDomestic Dial-in Number: (888) 660-6127 International Dial-in Number: ...
Cached Medicine Technology:Studies Show That TSH Is Unreliable in the Diagnosis of Hypothyroidism According to Article Contributed by Kent Holtorf, M.D. in Clinical Geriatrics 2Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation 2
(Date:7/24/2014)... (PRWEB) July 24, 2014 In ... Tuesday, President Obama cited the Atlanta BeltLine Workforce ... programs from across the country ( http://www.whitehouse.gov/ready-to-work ... an essential pillar of U.S. economic strategy and ... , “This recognition from President Obama highlights the ...
(Date:7/24/2014)... University, working with high-throughput data generated by breast ... devised a computational method to determine how gene ... malignant and as they respond to potential cancer ... interact with each other in laboratory-grown cells is ... online journal PLOS Computational Biology . , ...
(Date:7/24/2014)... rare procedure occasionally performed during Jewish circumcisions that involves ... herpes simplex virus type 1 (HSV-1) transmissions documented in ... conducted by Penn Medicine researchers and published online ... Society found. The reviewers, from Penn,s ... in New York, Canada and Israel. , The practiceknown ...
(Date:7/24/2014)... Lynn E. Taylor, M.D., director of The ... the July, 2014 Rhode Island Medical Journal ... eliminating hepatitis c virus infection (hep c or ... capacity to address other health challenges, and improve ... the United States, Taylor says, include lack of ...
(Date:7/24/2014)... July 24, 2014 Plaintiffs in ... ) against the manufacturer of Delatestryl, alleging they ... with the low testosterone injection, Bernstein Liebhard LLP ... in the Ontario Superior Court of Justice on ... low testosterone therapy is associated with an increased ...
Breaking Medicine News(10 mins):Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 4Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 5Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Link between ritual circumcision procedure and herpes infection in infants examined 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 3Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 4Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 3
... System in U.S. receives a low score (66 out ... first national scoring system of the 18-member Commonwealth Fund ... in promoting better health care systems for low-income and ... rankings were based on the scoring in various areas ...
... recent study reports that while teachers and students prefer ... and abortion rates especially in UK schools. When teen ... many influencing factors – the officials said. The study, ... was published in the British Medical Journal, covered about ...
... Fr Angelo D'Agostino SJ, a Jesuit priest, well-known for his ... Monday at the age of 80. ,He was the ... centre for abandoned HIV-positive children. ,Fr Joachim Omolo Ouko ... tribute to Fr Angelo D'Agostino SJ ,He said, "Father D'Agostino ...
... Ovarian cancer continues to be a stealthy killer in Australia ... in the advanced stages. Reports reveal that less than half ... beyond five years. Only about 42% of patients survive when ... a Federal government report. The survival rate is low for ...
... in how insects develop from larvae to adults have ... failure// to be effective in preventing and reducing cardiac ... Davis research published in the early online edition of ... ,The research, led by cardiologist and cell biologist Nipavan ...
... woman and a mother of two children died of breast cancer ... in Sheffield. //Dr.John Philip was not qualified to read mammograms according ... Trust, David Jackson. ,The woman who is identified as ... Philip told her that she was normal. When she went for ...
Cached Medicine News:Health News:Insect Protein Effective for Treating Heart Enlargement, Arrythmias 2
... TraceMasterVue is a cutting-edge ... rich, thin-client functionality and convenient, ... clinical, administrative and information technology ... productivity, lower costs, and improved ...
... testing within reach of virtually any facility...from ... most advanced cardiology hospital. This PC-based system ... options for a Philips ergonomic stress cart ... StressVue is designed to interface with the ...
A component of the 3M Littmann Electronic Stethoscope Model 4000...
... with the challenge of,controlling costs while ... patient data,management is critical. INFINITY modular,patient ... important clinical information,wherever you are in ... concept,makes your job easier. You can ...
Medicine Products: